Shanxi Zhendong Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
October 27, 2021 at 12:43 pm
Share
Shanxi Zhendong Pharmaceutical Co.,Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 4,052.41 million compared to CNY 3,372.46 million a year ago. Revenue was CNY 4,052.41 million compared to CNY 3,372.46 million a year ago. Net income was CNY 323.01 million compared to CNY 207 million a year ago. Basic earnings per share from continuing operations was CNY 0.3144 compared to CNY 0.2015 a year ago. Diluted earnings per share from continuing operations was CNY 0.3144 compared to CNY 0.2015 a year ago.
Shanxi Zhendong Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, production and sale of Chinese patent drugs, chemical raw materials and preparations. The Company's main products include anti-tumor series, cardiovascular and cerebrovascular series, anti-infection series, digestive system series, vitamin nutrition series, respiratory system series, antipyretic analgesic series and nervous system series. The Company is also involved in the cultivation of medicinal herbs, as well as the wholesale and retail of pharmaceutical products. The Company distributes its products in domestic market, with North China market as its main market.